Free tool
Rare disease stocks
We cover 3 companies grouped under the Rare disease theme. The median market value in the group is $3.79B. Across the group, the median move over the past trading day is +0.71%. Price change over the past year runs from −15.3% to +232.7% across the middle 80 percent of the group, with a median of −15.1%.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
3 of 268 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| 0HI3.L | Arrowhead Pharmaceuticals, Inc. | $6.98B | Mid cap | +294.59% |
| CAMX.ST | Camurus AB (publ) | $3.79B | Mid cap | −15.35% |
| 0RD1.L | Camurus AB (publ) | $2.84B | Mid cap | −15.10% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.